Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

TTScan Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
T

TScan Therapeutics, Inc.

$0.35Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $1.05M. Net result −$30.36M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $1.05M. Running result $1.05M. Revenue: $1.05M.
  • Cost of revenue: $0. Running result $1.05M.
  • Gross profit: $1.05M. Running result $1.05M.
  • Research and development: −$23.4M. Running result −$22.35M.
  • General and administrative: −$8.14M. Running result −$30.49M.
  • Operating income: −$30.49M. Running result −$30.49M.
  • Other income: $134K. Running result −$30.36M.
  • Pre-tax loss: −$30.36M. Running result −$30.36M.
  • Income tax benefit: $0. Running result −$30.36M.
  • Net loss: −$30.36M. Running result −$30.36M.